Newsfeeds - Spark Newswire

1 minute read

Chimerix Confirms Earlier Report Co Awarded BARDA Contract For TEMBEXA As Medical Countermeasure For Smallpox

Today, 6:30 PM

- Initial Procurement of 319,000 Treatment Courses for $115M with Additional Procurements at BARDA's Discretion Over 10 Years – - Emergent BioSolutions, Inc. Payment Increases

CMRX

1 minute read

Chimerix Wins $126.9M Department Of Health And Human Services Contract

By Benzinga Newsdesk

Today, 6:30 PM

https://www.usaspending.gov/award/CONT_AWD_75A50122C00047_7505_-NONE-_-NONE-

CMRX

1 minute read

Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed

By Vandana Singh

Today, 6:30 PM

According to the World Health Organization, health officials are witnessing early signs that the new monkeypox case growth may be…

AEMD

1 minute read

‘Monkeypox Outbreak Shows Signs of Cooling in U.S. and Globally’ -WSJ Report

By Benzinga Newsdesk

Today, 6:30 PM

https://www.wsj.com/articles/monkeypox-outbreak-shows-signs-of-cooling-in-u-s-and-globally-11661526042?mod=e2tw

AEMD

1 minute read

UK Says Monkeypox Vaccines To Be Piloted In Smaller But ‘Equally Effective’ Doses

By Benzinga Newsdesk

Today, 6:30 PM

-Reuters

AEMD

1 minute read

Global
News

UK Supplies Of Monkeypox Vaccine In Danger Of Running Out This Month; UK Will Run Out Of Monkeypox Vaccines In About Two To Three Weeks, With No New Shipments Expected Until Late September

By Bill Haddad

Today, 6:30 PM

-Reuters, citing FT

AEMD

1 minute read

FDA
News

U.S. Officials Preparing To Give Emergency Clearance To Technique For Extending Supply Of Bavarian Nordic’s Monkeypox Vaccine

By Benzinga Newsdesk

Today, 6:30 PM

-Bloomberg

AEMD

1 minute read

Earnings

Chimerix: Q2 Earnings Insights

By Benzinga Insights

Today, 6:30 PM

Chimerix (NASDAQ:CMRX) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

CMRX

1 minute read

Chimerix Q2 EPS $(0.27) Misses $(0.24) Estimate, Sales $440.00K Beat $20.00K Estimate

By Benzinga Newsdesk

Today, 6:30 PM

Chimerix (NASDAQ:CMRX) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.24) by 12.5 percent. This is a 28.57 percent decrease over losses of $(0.21) per share from the

CMRX

1 minute read

President Biden Weighs Health Emergency Authorities For Monkeypox

By Benzinga Newsdesk

Today, 6:30 PM

-Politico

AEMD